Real-world effectiveness and safety of belantamab mafodotin monotherapy in patients with relapsed/refractory multiple myeloma treated in Europe

Haematologica. 2026 Jan 22. doi: 10.3324/haematol.2025.289034. Online ahead of print.

Abstract

Not available.